Literature DB >> 2454766

Construction and clinical validation of a sensitive and specific assay for serum mature calcitonin using monoclonal anti-peptide antibodies.

P Motté1, P Vauzelle, P Gardet, P Ghillani, B Caillou, C Parmentier, C Bohuon, D Bellet.   

Abstract

Using calcitonin (CT) as an hapten, we have generated a library of monoclonal antibodies. Six monoclonal antibodies were developed and analyzed with respect to affinity and specificity for epitopes on CT by enzyme linked immunosorbent assay and radioimmunoassay. These antibodies were used in the construction and the optimization of a two-site monoclonal immunoradiometric assay (m-IRMA) for CT. We used a combination of two monoclonal antibodies to develop an assay which is rapid (overnight incubation), sensitive (10 pg/ml) and strictly specific for the mature form of calcitonin, ie the 32 amino acid-long polypeptide bearing a prolineamide as the C-terminal residue. This assay was utilized to demonstrate that mature calcitonin circulates as heterogeneous molecular species resulting from polymerization of calcitonin by disulphide linkage and/or by aggregation on irrelevant proteins. The clinical relevance of this assay was studied on a series of patients with medullary carcinoma of the thyroid (MCT) and the characteristics of the assay was compared with those of a conventional polyclonal radioimmunoassay. The m-IRMA for CT proved to be useful for both the diagnosis and the follow-up of MCT.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2454766     DOI: 10.1016/0009-8981(88)90365-8

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  5 in total

1.  Development and application of a novel sensitive immunometric assay for calcitonin in a large cohort of patients with medullary and differentiated thyroid cancer, thyroid nodules, and autoimmune thyroid diseases.

Authors:  Cléber P Camacho; Susan C Lindsey; Teresa S Kasamatsu; Alberto L Machado; João Roberto M Martins; Rosa Paula M Biscolla; Magnus R Dias da Silva; José Gilberto H Vieira; Rui M B Maciel
Journal:  Eur Thyroid J       Date:  2014-06-18

2.  Evaluation of sensitive PDN-21 (katacalcin) determination as tumor marker in medullary thyroid carcinoma.

Authors:  E Blind; F Raue; T Klaiber; A Zink; J Schroth; H Buhr; R Ziegler
Journal:  J Endocrinol Invest       Date:  1992-02       Impact factor: 4.256

3.  Malignant pheochromocytoma: clinical, biological, histologic and therapeutic data in a series of 20 patients with distant metastases.

Authors:  M Schlumberger; C Gicquel; J Lumbroso; F Tenenbaum; E Comoy; J Bosq; E Fonseca; P P Ghillani; B Aubert; J P Travagli
Journal:  J Endocrinol Invest       Date:  1992-10       Impact factor: 4.256

4.  Calcitonin levels in normal individuals with new highly sensitive chemiluminescent enzyme immunoassay.

Authors:  H Suzuki
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

5.  Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma.

Authors:  N Abdelmoumene; M Schlumberger; P Gardet; A Roche; J P Travagli; C Francese; C Parmentier
Journal:  Br J Cancer       Date:  1994-06       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.